CDC支持全球HPV疫苗接种、宫颈癌筛查与监测的活动
宫颈癌发病和死亡负担高,尤其在发展中国家,多数可通过HPV疫苗、筛查和及时治疗预防。美国CDC提供技术援助支持HPV疫苗试点项目与评估、实验室活动,并与全球伙伴制定筛查推荐和手册、创建标准化评估工具、培训流行病学家、支持癌症登记中心建设。
要点
- 多数宫颈癌可通过HPV疫苗接种、筛查和及时治疗预防。
- CDC为全球HPV疫苗试点项目与规划提供技术援助和评估。
- CDC支持全球宫颈癌筛查推荐制定、监测与癌症登记建设。
核心结论
- CDC通过技术援助、合作制定筛查推荐、培训与监测支持全球宫颈癌预防。
研究设计与样本
- 本文为CDC活动描述,未报告系统检索或研究样本。
主要发现
- CDC提供全球技术援助以实施和评估HPV疫苗试点项目与规划及实验室相关HPV活动。
- CDC与全球伙伴制定全球宫颈癌筛查推荐和手册、实施筛查、创建标准化评估工具并监测结局。
- CDC通过现场流行病学培训项目培训癌症预防流行病学家,并支持WHO开发癌症登记中心及估算人群癌症登记成本。
关键数值与推荐
- 多数宫颈癌可通过HPV疫苗接种、筛查和及时治疗预防。
临床怎么用
- 上述活动推动全球免疫、监测和公共卫生人力建设,服务于全球卫生安全议程行动包。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cervical cancer incidence and mortality rates are high, particularly in developing countries. Most cervical cancers can be prevented by human papillomavirus (HPV) vaccination, screening, and timely treatment. The US Centers for Disease Control and Prevention (CDC) provides global technical assistance for implementation and evaluation of HPV vaccination pilot projects and programs and laboratory-related HPV activities to assess HPV vaccines. CDC collaborates with global partners to develop global cervical cancer screening recommendations and manuals, implement screening, create standardized evaluation tools, and provide expertise to monitor outcomes. CDC also trains epidemiologists in cancer prevention through its Field Epidemiology Training Program and is working to improve cancer surveillance by supporting efforts of the World Health Organization in developing cancer registry hubs and assisting countries in estimating costs for developing population-based cancer registries. These activities contribute to the Global Health Security Agenda action packages to improve immunization, surveillance, and the public health workforce globally.
引用
- Senkomago V, Duran D, Loharikar A, et al. CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide. Emerg Infect Dis. 2017. PMID: 29155666. doi:10.3201/eid2313.170603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。